Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Chronic Heart Failure

Free Subscription 25.08.2025 7 Am J Cardiol 1 Circ Cardiovasc Imaging 2 Circ Cardiovasc Interv 6 Circ Heart Fail 1 Circ Res 4 Circulation 4 Eur Heart J 12 Eur J Heart Fail 1 Heart 5 Int J Cardiol 2 J Am Coll Cardiol 7 J Card Fail 1 J Cardiol 2 J Cardiovasc Pharmacol 1 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Cardiol

1. AKBAR UA, Taha MB, Arshad HB, Patel KV, et al
   Young Adults Undergoing Percutaneous Coronary Intervention for Myocardial Infarction in the United States, 2011-2023.
   Am J Cardiol. 2025 May 10:S0002-9149(25)00295.
   PubMed         Abstract available
   
   
2. XIA H, Li J, Dong J
   Clinical Characteristics and Prognosis of Acute Heart Failure in Patients with Chronic Obstructive Pulmonary Disease.
   Am J Cardiol. 2025 Aug 15:S0002-9149(25)00480.
   PubMed         Abstract available
   
   
3. GIORGI J, Cristodulo R, Vaca C, Urena D, et al
   Clinical and Epidemiological Profile of Heart Failure Patients with Chagas Disease: Insights from the SEPE-HF Registry.
   Am J Cardiol. 2025 Aug 18:S0002-9149(25)00486.
   PubMed        
   
   
4. BASHIR Z, Saxena R, Khalife W, Jneid H, et al
   Predictors of Sodium Glucose Co-Transporter-2 Inhibitor utilization in Elderly Heart Failure Patients: A Real-World Population-Level Dataset Analysis.
   Am J Cardiol. 2025 Aug 19:S0002-9149(25)00487.
   PubMed         Abstract available
   
   
5. VERELST FR, Zagorski B, Averbuch T, Bagur R, et al
   Long-term Healthcare Utilization and Outcomes in Patients Hospitalized for Heart Failure with and without Atrial Fibrillation.
   Am J Cardiol. 2025 Aug 20:S0002-9149(25)00479.
   PubMed         Abstract available
   
   
6. NIIZEKI T, Iwayama T, Sasaki T
   Prognostic Implications of Regional Cerebral Blood Flow Abnormality Assessed by Single Photon Emission Computed Tomography in Chronic Heart Failure Patients.
   Am J Cardiol. 2025 Aug 21:S0002-9149(25)00482.
   PubMed         Abstract available
   
   
7. HU Y, Li Y, Ma H, Sun L, et al
   Prevalence and Prognostic Differences Between Sarcopenia and Sarcopenic Obesity in Heart Failure.
   Am J Cardiol. 2025 Aug 21:S0002-9149(25)00494.
   PubMed         Abstract available
   
   

   
   Circ Cardiovasc Imaging

8. KIKUCHI DS, Quinaglia T, Bukhari S, Sharma K, et al
   Cardiac Magnetic Resonance Imaging in Heart Failure With Preserved Ejection Fraction.
   Circ Cardiovasc Imaging. 2025 Aug 22:e018519.
   PubMed         Abstract available
   
   

   
   Circ Cardiovasc Interv

9. MCKENNA M, Nadarajan N, Mukhopadhyay S, Ozkor M, et al
   Shorter Time to Transcatheter Aortic Valve Implantation Is Associated With Improved Outcomes in Acute Decompensated Aortic Stenosis.
   Circ Cardiovasc Interv. 2025 May 23:e014915.
   PubMed         Abstract available
   
   
10. BROWN K, Xu K, Hahn RT, Pibarot P, et al
    Impact of Coronary Artery Disease on Cardiovascular Outcomes Differs Between Men and Women With Severe Aortic Stenosis.
    Circ Cardiovasc Interv. 2025 May 27:e014999.
    PubMed         Abstract available
    
    

    
    Circ Heart Fail

11. FONTANA M, Berk JL, Drachman B, Garcia-Pavia P, et al
    Changing Treatment Landscape in Transthyretin Cardiac Amyloidosis.
    Circ Heart Fail. 2025;18:e012112.
    PubMed         Abstract available
    
    
12. DEFILIPPIS EM, Masotti M, Donald EM, Eichler J, et al
    Sex Differences in Utilization of Donation After Circulatory Death Donors for Heart Transplantation and Associated Outcomes.
    Circ Heart Fail. 2025 Jun 26:e012835. doi: 10.1161/CIRCHEARTFAILURE.125.012835.
    PubMed         Abstract available
    
    
13. ROTH J, Lieske JC, Herrmann SM, Arruda-Olson AM, et al
    Performance of Creatinine and Cystatin C-Based Equations to Estimate Glomerular Filtration Rate Among Patients With Heart Failure.
    Circ Heart Fail. 2025 Aug 15:e013014. doi: 10.1161/CIRCHEARTFAILURE.125.013014.
    PubMed         Abstract available
    
    
14. MANIAN N, Doering M, Joynt-Maddox K, Sweitzer N, et al
    Socioeconomic Status in Large Heart Failure Trials: A Call to Action.
    Circ Heart Fail. 2025 Aug 19:e013031. doi: 10.1161/CIRCHEARTFAILURE.125.013031.
    PubMed        
    
    
15. CHITSAZAN M, Parekh JK, Kosyakovsky LB, Nemeth SM, et al
    Natriuretic Peptide Cut Points for Heart Failure Classification in Individuals With and Without Obesity.
    Circ Heart Fail. 2025 Aug 20:e013112. doi: 10.1161/CIRCHEARTFAILURE.125.013112.
    PubMed         Abstract available
    
    
16. HACIL A, Antakly Hanon Y, Lacour A, David JP, et al
    Efficacy and Safety of SGLT2 Inhibitors in Heart Failure: Observational Evidence in Geriatric Patients AGING-HF.
    Circ Heart Fail. 2025 Aug 20:e012794. doi: 10.1161/CIRCHEARTFAILURE.125.012794.
    PubMed         Abstract available
    
    

    
    Circ Res

17. KNEUER JM, Muller M, Erbe S, Kokot KE, et al
    Circulating Immune Cell Signature Analysis in HFpEF Across Species.
    Circ Res. 2025;137:682-698.
    PubMed         Abstract available
    
    

    
    Circulation

18. SCHUMACHER KR, Rosenthal DN, Batazzi A, Yu S, et al
    The Impact of Fontan Circulatory Failure on Heart Transplant Survival: A 20-Center Retrospective Cohort Study.
    Circulation. 2025 Jul 9. doi: 10.1161/CIRCULATIONAHA.124.072961.
    PubMed         Abstract available
    
    
19. XIONG J, Zhang S, Geng Z, Lin J, et al
    An Aberrant Resurgence of Endogenous Retroviruses Prompts Myocarditis and Heart Failure.
    Circulation. 2025 Aug 18. doi: 10.1161/CIRCULATIONAHA.125.074845.
    PubMed         Abstract available
    
    
20. DOCHERTY KF, Henderson AD, Jhund PS, Solomon SD, et al
    Response by Docherty et al to Letter Regarding Article, "Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF Trial".
    Circulation. 2025;152:e65-e66.
    PubMed        
    
    
21. KORNELIUS E
    Letter by Kornelius Regarding Article, "Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF Trial".
    Circulation. 2025;152:e64.
    PubMed        
    
    

    
    Eur Heart J

22. GUALANDRO DM, Masip J, Halvorsen S, Price S, et al
    Acute heart failure in non-cardiac surgery.
    Eur Heart J. 2025 Aug 21:ehaf559. doi: 10.1093.
    PubMed         Abstract available
    
    
23. 
    Correction to: Telemonitoring for heart failure: a meta-analysis.
    Eur Heart J. 2025 Aug 21:ehaf509. doi: 10.1093.
    PubMed        
    
    
24. ABDIN A, Sawan N, Katbeh A
    Uniting for heart failure awareness in Syria.
    Eur Heart J. 2025 Aug 21:ehaf500. doi: 10.1093.
    PubMed        
    
    
25. SEGAN L, Kistler PM, Nanayakkara S, Taylor A, et al
    Withdrawal of heart failure therapy after atrial fibrillation rhythm control with ejection fraction normalization: the WITHDRAW-AF trial.
    Eur Heart J. 2025 Aug 12:ehaf563. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Eur J Heart Fail

26. ANKER MS, Mahabadi AA, Totzeck M, Tewes M, et al
    Randomized investigation of heart failure therapy in patients with advanced cancer at risk of cardiac wasting: Rationale and design of the EMPATICC trial.
    Eur J Heart Fail. 2025 Aug 26. doi: 10.1002/ejhf.3799.
    PubMed         Abstract available
    
    
27. PANDEY A, Segar MW, Keshvani N, Llacer P, et al
    Diuretic resistance and the efficacy of hydrochlorothiazide in acute decompensated heart failure: A post-hoc analysis of the CLOROTIC trial.
    Eur J Heart Fail. 2025 Aug 26. doi: 10.1002/ejhf.70002.
    PubMed         Abstract available
    
    
28. MARKWIRTH P, Hoevelmann J, Tokcan M, Haring B, et al
    What's new in heart failure? July 2025.
    Eur J Heart Fail. 2025;27:1155-1158.
    PubMed        
    
    
29. BAUDRY G, Crespo-Leiro MG, Delmas C, Guidetti F, et al
    Identifying and overcoming barriers to referral in advanced heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC.
    Eur J Heart Fail. 2025 Aug 17. doi: 10.1002/ejhf.70003.
    PubMed         Abstract available
    
    
30. ZUIN M, Temporelli PL, Metra M, Savarese G, et al
    Heart failure-attributed mortality in Europe, 2012-2021.
    Eur J Heart Fail. 2025 Aug 17. doi: 10.1002/ejhf.70001.
    PubMed         Abstract available
    
    
31. ROSANO GMC, Bayes-Genis A, Kinugawa K, Teerlink JR, et al
    Healthcare system deficiencies should never be employed as justification for delivering sub-standard care to heart failure patients. Letter regarding the article 'Serial assessment of left ventricular ejection fraction for the management of heart fail
    Eur J Heart Fail. 2025 Aug 15. doi: 10.1002/ejhf.3772.
    PubMed        
    
    
32. PALAZZUOLI A, Pellicori P, Cleland JGF
    Reply to 'Healthcare system deficiencies should never be employed as justification for delivering sub-standard care to heart failure patients'.
    Eur J Heart Fail. 2025 Aug 15. doi: 10.1002/ejhf.3770.
    PubMed        
    
    
33. BUTT JH, McMurray JJV
    Reply to 'Impact of misclassification bias on interpretation of finerenone efficacy in chronic obstructive pulmonary disease and heart failure with mildly reduced/preserved ejection fraction: A critical appraisal of the FINEARTS-HF sub-analysis'.
    Eur J Heart Fail. 2025 Aug 15. doi: 10.1002/ejhf.3804.
    PubMed        
    
    
34. QUATAERT I, Blondeel M, Trenson S, Ingelaere S, et al
    Incidences and clinical outcomes of patients with a single or dual chamber implantable cardioverter-defibrillator developing an indication for cardiac resynchronization therapy.
    Eur J Heart Fail. 2025;27:1262-1269.
    PubMed         Abstract available
    
    
35. KAYE DM, Wang XS, Koay YC, Li M, et al
    Mechanical unloading is accompanied by reverse metabolic remodelling in the failing heart: Identification of a novel citraconate-mediated pathway.
    Eur J Heart Fail. 2025;27:1342-1352.
    PubMed         Abstract available
    
    
36. KRAMMER T, Baier MJ, Hegner P, Zschiedrich T, et al
    Cardioprotective effects of semaglutide on isolated human ventricular myocardium.
    Eur J Heart Fail. 2025;27:1315-1325.
    PubMed         Abstract available
    
    
37. LONGINOW J, Mirzai S, Chen PH, Hanna M, et al
    Skeletal muscle and subcutaneous fat quantity as prognostic indicators in cardiac amyloidosis.
    Eur J Heart Fail. 2025;27:1294-1303.
    PubMed         Abstract available
    
    

    
    Heart

38. BUYADAA O, Wolfe R, Tonkin AM, Reid CM, et al
    Kidney function and risk of heart failure in older adults: findings from a prospective cohort study.
    Heart. 2025 Aug 22:heartjnl-2025-325700. doi: 10.1136/heartjnl-2025-325700.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

39. MEGHWAR S, Bhagwan R, Naqvi SMM, Wali F, et al
    Trends in heart failure-related mortality among psychoactive drug users in the United States: A nationwide cross-sectional analysis of the CDC WONDER database.
    Int J Cardiol. 2025;441:133790.
    PubMed         Abstract available
    
    
40. PALM CL, de Wit S, Gorter TM, Rienstra M, et al
    Reply to Letter to the Editor: Beyond the gut: Systemic levels of short-chain fatty acids are altered in patients with heart failure.
    Int J Cardiol. 2025 Aug 19:133809. doi: 10.1016/j.ijcard.2025.133809.
    PubMed        
    
    
41. REN JM, Wang YG, Zheng JL, Wang WY, et al
    Thyroid hormones were associated with incident heart failure subtypes and changes in cardiac structure and function: results from the atherosclerosis risk in communities study.
    Int J Cardiol. 2025;441:133794.
    PubMed         Abstract available
    
    
42. NOIRI JI, Tanaka H
    Authors' reply to Wang on frailty dynamics and implementation in super aged heart failure.
    Int J Cardiol. 2025 Aug 18:133799. doi: 10.1016/j.ijcard.2025.133799.
    PubMed        
    
    
43. CARLUCCIO E, Fortuni F, Ambrosio G
    Don't stop now: The imperative to maintain SGLT2 inhibitors in older patients with heart failure.
    Int J Cardiol. 2025;441:133775.
    PubMed        
    
    

    
    J Am Coll Cardiol

44. CAI A, Liu L, Feng Y, Li L, et al
    Comparison of Fixed vs Age-Adjusted NT-proBNP Cutoffs to Define Pre-Heart Failure.
    J Am Coll Cardiol. 2025;86:625-629.
    PubMed        
    
    
45. KAUL S
    Evidentiary Landscape of Heart Failure Therapies, Regulatory Decisions, and Translation Into Guidelines.
    J Am Coll Cardiol. 2025;86:610-624.
    PubMed         Abstract available
    
    

    
    J Card Fail

46. BHIMARAJ A, Garan AR, Kong Q, Kim J, et al
    Comparison of Heart Failure Cardiogenic Shock patients with Axillary and Femoral Intra-aortic Balloon Pump: A CSWG report.
    J Card Fail. 2025 Aug 20:S1071-9164(25)00364.
    PubMed         Abstract available
    
    
47. LEE H, Kim EJ, Han SW, Park SM, et al
    Advancements and Challenges in Acute Heart Failure Management in Korea: Initial Report and Insights from the Korean Heart Failure III Registry.
    J Card Fail. 2025 Aug 20:S1071-9164(25)00371.
    PubMed         Abstract available
    
    
48. SIMPSON M, Bechthold AC, Grady KL
    Equity in heart failure follow-up: aligning resource allocation with risk.
    J Card Fail. 2025 Aug 20:S1071-9164(25)00356.
    PubMed        
    
    
49. BERG DD, Docherty K, Talebi A, Sattar N, et al
    Growth differentiation factor-15 and the effect of dapagliflozin in heart failure: insights from the DAPA-HF trial.
    J Card Fail. 2025 Aug 15:S1071-9164(25)00357.
    PubMed         Abstract available
    
    
50. LALA A, Beavers C, Blumer V, Brewer L, et al
    The Continuum of Prevention and Heart Failure in Cardiovascular Medicine: A Joint Scientific Statement from the Heart Failure Society of America and The American Society for Preventive Cardiology.
    J Card Fail. 2025 Aug 7:S1071-9164(25)00327.
    PubMed         Abstract available
    
    
51. HONG Y, Hess NR, Ziegler LA, Dorken-Gallastegi A, et al
    Right Ventricular Mass Oversizing Is Associated With Improved Post-transplant Survival in Heart Transplant Recipients With Elevated Transpulmonary Gradient.
    J Card Fail. 2025;31:1152-1163.
    PubMed         Abstract available
    
    
52. BERTOT JH, Varshney AS, Moscone A, Claggett BL, et al
    Effectiveness of Virtual Care Team Guided Management of Hospitalized Patients with HFrEF by Ethnicity.
    J Card Fail. 2025;31:1127-1135.
    PubMed         Abstract available
    
    

    
    J Cardiol

53. FUJIMOTO Y, Kitai T, Horiuchi Y, Kondo T, et al
    Chronic kidney disease and contemporary guideline-directed medical therapy during hospitalization in patients with heart failure: Insights from PRE-UPFRONT-HF.
    J Cardiol. 2025 Aug 21:S0914-5087(25)00211-4. doi: 10.1016/j.jjcc.2025.
    PubMed         Abstract available
    
    

    
    J Cardiovasc Pharmacol

54. WEN S, Liu X, Liu L, Hu Y, et al
    Landscape of Berberine Targets: A Potential Pharmacological Insight for Heart failure Treatment.
    J Cardiovasc Pharmacol. 2025 Aug 20. doi: 10.1097/FJC.0000000000001750.
    PubMed         Abstract available
    
    
55. GALLUZZO A, Bertaina M, Vishram-Nielsen JKK, Camilli M, et al
    Current Practices and Perspectives on the Use of Intravenous Vasodilators in Acute Heart Failure: An International Survey.
    J Cardiovasc Pharmacol. 2025 Aug 20. doi: 10.1097/FJC.0000000000001753.
    PubMed         Abstract available
    
    

    
    PLoS One

56. SUITA K, Hayakawa Y, Hoshino Y, Cai W, et al
    Water-soluble vidarabine derivatives alleviate catecholamine-induced heart failure and arrhythmia without impairing cardiac function in mice.
    PLoS One. 2025;20:e0330507.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

57. SCOTT B, Greenberg L, Squarci C, Campbell KS, et al
    Danicamtiv reduces myosin's working stroke but activates the thin filament by accelerating actomyosin attachment.
    Proc Natl Acad Sci U S A. 2025;122:e2515786122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.